肌萎缩侧索硬化
SOD1
突变
遗传学
超氧化物歧化酶
人口
生物
单倍型
歧化酶
表型
基因突变
基因
疾病
医学
等位基因
病理
氧化应激
生物化学
环境卫生
作者
Mariusz Berdyński,Magdalena Kuźma‐Kozakiewicz,Claudia Ricci,Justyna Kubiszewska,Stéphanie Millecamps,François Salachas,Anna Łusakowska,Paola Carrera,Vincent Meininger,Stefania Battistini,Hubert Kwieciński,Cezary Żekanowski
标识
DOI:10.3109/17482968.2011.600316
摘要
Mutations in the superoxide dismutase-1 (SOD1) gene have been found in 12-23% of patients with a diagnosis of ALS. Here we describe a large ALS Polish family with a branch in France, carrying a G41S mutation in the SOD1, and characterized by an early onset of the disease and extremely short survival time. The mutation has been initially detected in Italian ALS families with common founder effect. However, in the Polish population the G41S mutation most probably originated from an independent mutation event, as indicated by haplotype analysis. Collected data support the hypothesis that a SOD1 mutation is not the sole factor determining the clinical ALS phenotype.
科研通智能强力驱动
Strongly Powered by AbleSci AI